306 related articles for article (PubMed ID: 18489646)
41. [Antitumor properties of the bisphosphonate zoledronate and potential therapeutic implications in the clinic].
Clézardin P
Bull Cancer; 2010 Aug; 97(8):937-49. PubMed ID: 20595092
[TBL] [Abstract][Full Text] [Related]
42. Recurrent scrotal hemangiomas during treatment with sunitinib.
Tonini G; Intagliata S; Cagli B; Segreto F; Perrone G; Onetti Muda A; Santini D; Persichetti P
J Clin Oncol; 2010 Dec; 28(35):e737-8. PubMed ID: 20823408
[No Abstract] [Full Text] [Related]
43. New results from the use of bisphosphonates in cancer patients.
Coleman R; Gnant M
Curr Opin Support Palliat Care; 2009 Sep; 3(3):213-8. PubMed ID: 19561507
[TBL] [Abstract][Full Text] [Related]
44. Role of the nurse in preserving patients' independence.
Maxwell C
Eur J Oncol Nurs; 2007; 11 Suppl 2():S38-41. PubMed ID: 17768093
[TBL] [Abstract][Full Text] [Related]
45. Management of bone metastases in cancer: a review.
Selvaggi G; Scagliotti GV
Crit Rev Oncol Hematol; 2005 Dec; 56(3):365-78. PubMed ID: 15978828
[TBL] [Abstract][Full Text] [Related]
46. Prevalence and risk factors of bisphosphonate-associated osteonecrosis of the jaw in prostate cancer patients with advanced disease treated with zoledronate.
Walter C; Al-Nawas B; Grötz KA; Thomas C; Thüroff JW; Zinser V; Gamm H; Beck J; Wagner W
Eur Urol; 2008 Nov; 54(5):1066-72. PubMed ID: 18602738
[TBL] [Abstract][Full Text] [Related]
47. Lack of prophylactic effect of incadronate on skeletal lesions associated with implants of prostate cancer.
Hikosaka A; Futakuchi M; Ogiso T; Suzuki S; Kohri K; Shirai T
Eur Urol; 2006 Jan; 49(1):176-82. PubMed ID: 16310925
[TBL] [Abstract][Full Text] [Related]
48. Bisphosphonates--role in cancer therapies.
Mehrotra B
J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):19-26. PubMed ID: 19371811
[No Abstract] [Full Text] [Related]
49. [Zoledronic acid for bone metastases due to advanced renal cell carcinoma under chronic hemodialysis--a report of two cases].
Arima S; Shiroki R; Mori S; Maruyama T; Sasaki H; Kusaka M; Miyakawa S; Hayakawa K; Hoshinaga K
Nihon Hinyokika Gakkai Zasshi; 2008 Jul; 99(5):660-5. PubMed ID: 18697474
[TBL] [Abstract][Full Text] [Related]
50. Failure of 5-day vinblastine infusion in the treatment of patients with renal cell carcinoma.
Tannock IF; Evans WK
Cancer Treat Rep; 1985 Feb; 69(2):227-8. PubMed ID: 3882231
[No Abstract] [Full Text] [Related]
51. Burden of bone disease.
Kinnane N
Eur J Oncol Nurs; 2007; 11 Suppl 2():S28-31. PubMed ID: 17768092
[TBL] [Abstract][Full Text] [Related]
52. [The role of bisphosphonates in the treatment of bone metastases from urogenital cancer ].
Colombel M
Prog Urol; 2003 Apr; 13(2 Suppl 1):18-23. PubMed ID: 12815805
[No Abstract] [Full Text] [Related]
53. Re: Rana R. McKay, Xun Lin, Julia J. Perkins, Daniel Y.C. Heng, Ronit Simantov, Toni K. Choueiri. Prognostic significance of bone metastases and bisphosphonate therapy in patients with renal cell carcinoma. Eur Urol 2014;66:502-9.
Beuselinck B; Wolter P; Broom R
Eur Urol; 2014 Sep; 66(3):e53-4. PubMed ID: 24836152
[No Abstract] [Full Text] [Related]
54. [TARTRAT-RESISTANT ACID PHOSPHATASE AS BONE'S RESORBTION MARKER IN PATIENTS WITH BONE METASTASES].
Dedkov AG; Boychuk SI; Stakhovsky EA; Kukushkina MN; Kovalchuk PA
Lik Sprava; 2015; (5-6):104-9. PubMed ID: 27089726
[TBL] [Abstract][Full Text] [Related]
55. Bisphosphonates in metastatic bone disease: renal safety matters.
Body JJ
Oncologist; 2005; 10 Suppl 1():1-2. PubMed ID: 16264105
[No Abstract] [Full Text] [Related]
56. Bisphosphonates in patients with renal cell carcinoma and bone metastases: a sunitinib global expanded-access trial subanalysis.
Vrdoljak E; Gore M; Leyman S; Szczylik C; Kharkevich G; Schöffski P; Torday L; Mardiak J; Zhang K; Sajben P; Sella A
Future Oncol; 2015; 11(20):2831-40. PubMed ID: 26118456
[TBL] [Abstract][Full Text] [Related]
57. Emerging role of bisphosphonates in the clinic--antitumor activity and prevention of metastasis to bone.
Lipton A
Cancer Treat Rev; 2008; 34 Suppl 1():S25-30. PubMed ID: 18486347
[TBL] [Abstract][Full Text] [Related]
58. [The role of surgery in bone metastases of renal cell carcinoma: 13 case reports].
Le Mouel S; Gaston A; Paule B
Prog Urol; 2008 Dec; 18(13):1045-9. PubMed ID: 19041809
[TBL] [Abstract][Full Text] [Related]
59. Zoledronate in the treatment of osteolytic bone metastases.
Lipton A
Br J Clin Pract Suppl; 1996 Sep; 87():21; discussion 22. PubMed ID: 8995015
[No Abstract] [Full Text] [Related]
60. Pharmacotherapy of bone metastases in breast cancer patients.
Petrut B; Simmons C; Broom R; Trinkaus M; Clemons M
Expert Opin Pharmacother; 2008 Apr; 9(6):937-45. PubMed ID: 18377337
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
